References
- Abe S, Yoshimura H, Nagaoka S, Monden N, Kinugasa S, Nagasue N, et al. Long-term results of operation for carcinoma of the stomach in T1/T2 stages: critical evaluation of the concept of early carcinoma of the stomach. J Am Coll Surg 1995;181:389-96
- Roukos DH. Current status and future perspectives in gastric cancer management. Cancer Treat Rev 2000;26:243-55 https://doi.org/10.1053/ctrv.2000.0164
- Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 2003;14 Suppl 2:ii31-6
-
Yoshioka T, Yamaguchi K, Kubota K, Saginoya T, Yamazaki T, Ido T, et al. Evaluation of
^{18}F$ -FDG PET in patients with advanced, metastatic, or recurrent gastric cancer. J Nucl Med 2003;44:690-9 - Yun M, Lim J, Noh S, Hyung WJ, Cheong JH, Bong JK, et al. Lymph Node Staging of Gastric Cancer Using FDG PET; A Comparison Study with CT. J Nucl Med 2005;46:1582-8
- Yun M, Kim HK, Kim HR, Kim TS, Cho A, Lee JD. Histopathologic features of adenocarcinomas of the stomach affecting FDG uptake on PET. J Nucl Med (Abstract). 2006; 466P
- Lee HJ, Yun M, Ko D, Ryu YH, Lee JD. Use of hydro-FDG PET in the detection of primary tumors of the stomach. J Nucl Med (Abstract). 2005;424P
-
Yun M, Choi HS, Yoo E, Bong JK, Ryu YH, Lee JD. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on
$^{18}F$ -FDG PET. J Nucl Med 2005;46:953-7 - De Potter T, Flamen P, Van Cutsem E, Penninckx F, Filez L, Bormans G, et al. Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging 2002;29:525-9 https://doi.org/10.1007/s00259-001-0743-8
- Stahl A, Ott K, Weber WA, Becker K, Link T, Siewert JR, et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging 2003;30:288-95 https://doi.org/10.1007/s00259-002-1029-5
- Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11:418-25 https://doi.org/10.1007/BF01655804
- Chen J, Cheong JH, Yun MJ, Kim J, Lim JS, Hyung WJ, et al. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer 2005;103:2383-90 https://doi.org/10.1002/cncr.21074
-
Kim SK, Kang KW, Lee JS, Kim HK, Chang HJ, Choi JY, et al. Assessment of lymph node metastases using
$^{18}F$ -FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging 2006;33:148-55 https://doi.org/10.1007/s00259-005-1887-8 -
Mochiki E, Kuwano H, Katoh H, Asao T, Oriuchi N, Endo K. Evaluation of
$^{18}F$ -2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg 2004;28:247-53 https://doi.org/10.1007/s00268-003-7191-5 - Gryspeerdt S, Clabout L, Van Hoe L, Berteloot P, Vergote IB. Intraperitoneal contrast material combined with CT for detection of peritoneal metastases of ovarian cancer. Eur J Gynaecol Oncol 1998;19:434-7
- Low RN, Barone RM, Lacey C, Sigeti JS, Alzate GD, Sebrechts CP. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology 1997;204:513-20 https://doi.org/10.1148/radiology.204.2.9240546
- Tanaka T, Kawai Y, Kanai M, Taki Y, Nakamoto Y, Takabayashi A. Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer. Am J Surg 2002;184: 433-6 https://doi.org/10.1016/S0002-9610(02)01004-8
-
Turlakow A, Yeung HW, Salmon AS, Macapinlac HA, Larson SM. Peritoneal carcinomatosis: role of
$^{18}F$ -FDG PET. J Nucl Med 2003;44:1407-12 - Ko D, Yun M, Lim J, Noh S, Ryu Y, Lee JD. Detection of peritoneal carcinomatosis in patients with gastric adenocarcinoma: Is PET more accurate than CT. J Nucl Med (Abstract) 2005;425P
- Lim J, Yun M, Kim M, Hyung WJ, Park MS, Choi JY, et al. The role of CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics 2006;26:143-56 https://doi.org/10.1148/rg.261055078
- Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002;224:748-56 https://doi.org/10.1148/radiol.2243011362
- Buyyounouski MK, Klump WJ, Konski A, Wu H, Adler LP. FDG PET imaging of signet-ring cell adenocarcinoma of the stomach. Clin Nucl Med 2005;30:118-9 https://doi.org/10.1097/00003072-200502000-00014
- Tian J, Chen L, Wei B, Shao M, Ding Y, Yin D, et al. The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies. Nucl Med Commun 2004;25:825-31 https://doi.org/10.1097/01.mnm.0000135042.54461.f6
- Jadvar H, Tatlidil R, Garcia AA, Conti PS. Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol 2003;58:215-21 https://doi.org/10.1016/S0009-9260(02)00477-4
- Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg 2000;87:236-42 https://doi.org/10.1046/j.1365-2168.2000.01360.x
- Ott K, Fink U, Becker K, Stahl A, Dittler HJ, Busch R, et al. Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 2003;21:4604-10
- Stahl A, Ott K, Schwaiger M, Weber WA. Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET. Eur J Nucl Med Mol Imaging 2004;31:1471-78 https://doi.org/10.1007/s00259-004-1626-6